Leukemia Research
Volume 29, Issue 8 , Pages 943-949 , August 2005

Retroviral expression screening of oncogenes in natural killer cell leukemia

  • Young Lim Choi

      Affiliations

    • Division of Functional Genomics, Jichi Medical School, 3311-1 Yakushiji, Kawachigun, Tochigi 329-0498, Japan
    • Division of Hematology, Department of Medicine, Juntendo University School of Medicine, Tokyo, Japan
    • ,
  • Ryozo Moriuchi

      Affiliations

    • Department of Molecular Microbiology and Immunology, Nagasaki University Graduate School of Medicine, Nagasaki, Japan
    • ,
  • Mitsujiro Osawa

      Affiliations

    • Center for Experimental Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan
    • ,
  • Atsushi Iwama

      Affiliations

    • Center for Experimental Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan
    • ,
  • Hideki Makishima

      Affiliations

    • Second Department of Internal Medicine, Shinshu University School of Medicine, Nagano, Japan
    • ,
  • Tomoaki Wada

      Affiliations

    • Division of Functional Genomics, Jichi Medical School, 3311-1 Yakushiji, Kawachigun, Tochigi 329-0498, Japan
    • ,
  • Hiroyuki Kisanuki

      Affiliations

    • Division of Functional Genomics, Jichi Medical School, 3311-1 Yakushiji, Kawachigun, Tochigi 329-0498, Japan
    • ,
  • Ruri Kaneda

      Affiliations

    • Division of Functional Genomics, Jichi Medical School, 3311-1 Yakushiji, Kawachigun, Tochigi 329-0498, Japan
    • ,
  • Jun Ota

      Affiliations

    • Division of Functional Genomics, Jichi Medical School, 3311-1 Yakushiji, Kawachigun, Tochigi 329-0498, Japan
    • CREST, Japan Science and Technology Agency, Saitama, Japan
    • ,
  • Koji Koinuma

      Affiliations

    • Division of Functional Genomics, Jichi Medical School, 3311-1 Yakushiji, Kawachigun, Tochigi 329-0498, Japan
    • ,
  • Madoka Ishikawa

      Affiliations

    • Division of Functional Genomics, Jichi Medical School, 3311-1 Yakushiji, Kawachigun, Tochigi 329-0498, Japan
    • ,
  • Shuji Takada

      Affiliations

    • Division of Functional Genomics, Jichi Medical School, 3311-1 Yakushiji, Kawachigun, Tochigi 329-0498, Japan
    • ,
  • Yoshihiro Yamashita

      Affiliations

    • Division of Functional Genomics, Jichi Medical School, 3311-1 Yakushiji, Kawachigun, Tochigi 329-0498, Japan
    • ,
  • Kazuo Oshimi

      Affiliations

    • Division of Hematology, Department of Medicine, Juntendo University School of Medicine, Tokyo, Japan
    • ,
  • Hiroyuki Mano

      Affiliations

    • Division of Functional Genomics, Jichi Medical School, 3311-1 Yakushiji, Kawachigun, Tochigi 329-0498, Japan
    • CREST, Japan Science and Technology Agency, Saitama, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 285 58 7449; fax: +81 285 44 7322.

Received 17 October 2004 ,Accepted 22 January 2005.

References 

  1. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November. J Clin Oncol. 1999;17:3835–3849
  2. Oshimi K. Leukemia and lymphoma of natural killer lineage cells. Int J Hematol. 2003;78:18–23
  3. Gelb AB, van de Rijn M, Regula DP, Cornbleet JP, Kamel OW, Horoupian DS, et al. Epstein–Barr virus-associated natural killer-large granular lymphocyte leukemia. Hum Pathol. 1994;25:953–960
  4. Sakajiri S, Kawamata N, Egashira M, Mori K, Oshimi K. Molecular analysis of tumor suppressor genes, Rb, p53, p16INK4A, p15INK4B and p14ARF in natural killer cell neoplasms. Jpn J Cancer Res. 2001;92:1048–1056
  5. Takakuwa T, Dong Z, Nakatsuka S, Kojya S, Harabuchi Y, Yang WI, et al. Frequent mutations of Fas gene in nasal NK/T cell lymphoma. Oncogene. 2002;21:4702–4705
  6. Hoshida Y, Hongyo T, Nakatsuka S, Nishiu M, Takakuwa T, Tomita Y, et al. Gene mutations in lymphoproliferative disorders of T and NK/T cell phenotypes developing in renal transplant patients. Lab. Invest. 2002;82:257–264
  7. Sugimoto KJ, Kawamata N, Sakajiri S, Oshimi K. Molecular analysis of oncogenes, ras family genes (N-ras, K-ras, H-ras), myc family genes (c-myc, N-myc) and mdm2 in natural killer cell neoplasms. Jpn J Cancer Res. 2002;93:1270–1277
  8. Hongyo T, Li T, Syaifudin M, Baskar R, Ikeda H, Kanakura Y, et al. Specific c-kit mutations in sinonasal natural killer/T-cell lymphoma in China and Japan. Cancer Res. 2000;60:2345–2347
  9. Aaronson SA. Growth factors and cancer. Science. 1991;254:1146–1153
  10. Yagita M, Huang CL, Umehara H, Matsuo Y, Tabata R, Miyake M, et al. A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation. Leukemia. 2000;14:922–930
  11. Robertson MJ, Cochran KJ, Cameron C, Le JM, Tantravahi R, Ritz J, et al. Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. Exp Hematol. 1996;24:406–415
  12. Pear WS, Nolan GP, Scott ML, Baltimore D. Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci USA. 1993;90:8392–8396
  13. Onishi M, Kinoshita S, Morikawa Y, Shibuya A, Phillips J, Lanier LL, et al. Applications of retrovirus-mediated expression cloning. Exp Hematol. 1996;24:324–329
  14. Kahn SM, Jiang W, Culbertson TA, Weinstein IB, Williams GM, Tomita N, et al. Rapid and sensitive nonradioactive detection of mutant K-ras genes via ‘enriched’ PCR amplification. Oncogene. 1991;6:1079–1083
  15. Kent WJ. BLAT—the BLAST-like alignment tool. Genome Res. 2002;12:656–664
  16. Ayllon V, Rebollo A. Ras-induced cellular events. Mol Membr Biol. 2000;17:65–73
  17. Goldschmidt-Clermont PJ, Janmey PA, Profilin . A weak CAP for actin and RAS. Cell. 1991;66:419–421
  18. Witke W, Sutherland JD, Sharpe A, Arai M, Kwiatkowski DJ. Profilin I is essential for cell survival and cell division in early mouse development. Proc Natl Acad Sci USA. 2001;98:3832–3836
  19. Kim YO, Park SH, Kang YJ, Koh HJ, Kim SH, Park SY, et al. Assignment of mitochondrial NAD(+)-specific isocitrate dehydrogenase beta subunit gene (IDH3B) to human chromosome band 20p13 by in situ hybridization and radiation hybrid mapping. Cytogenet Cell Genet. 1999;86:240–241
  20. Siu LL, Wong KF, Chan JK, Kwong YL. Comparative genomic hybridization analysis of natural killer cell lymphoma/leukaemia. Recognition of consistent patterns of genetic alterations. Am J Pathol. 1999;155:1419–1425
  21. Perentesis JP, Bhatia S, Boyle E, Shao Y, Shu XO, Steinbuch M, et al. RAS oncogene mutations and outcome of therapy for childhood acute lymphoblastic leukemia. Leukemia. 2004;18:685–692
  22. Santos E, Martin-Zanca D, Reddy EP, Pierotti MA, Della Porta G, Barbacid M. Malignant activation of a K-ras oncogene in lung carcinoma but not in normal tissue of the same patient. Science. 1984;223:661–664
  23. Motojima K, Urano T, Nagata Y, Shiku H, Tsurifune T, Kanematsu T. Detection of point mutations in the Kirsten-ras oncogene provides evidence for the multicentricity of pancreatic carcinoma. Ann Surg. 1993;217:138–143

PII: S0145-2126(05)00058-5

doi: 10.1016/j.leukres.2005.02.002

Leukemia Research
Volume 29, Issue 8 , Pages 943-949 , August 2005

Article Tools

* Image Usage & Resolution